Revvity reported $278.58M in Selling and Administration Expenses for its fiscal quarter ending in June of 2026.





Selling And Administration Expenses Change Date
Agilent USD 475M 10M Jun/2026
Align Technology USD 462.67M 2.67M Jun/2026
Bio Techne USD 109.34M 4.35M Mar/2026
Bio-Rad Laboratories USD 212M 400K Jun/2026
Bruker USD 238.9M 3.2M Jun/2026
Celltrion KRW 9.32B 3.39B Mar/2026
Charles River Laboratories USD 228.9M 69.47M Jun/2026
Cspc Pharmaceutical CNY 1.87B 95.62M Dec/2025
Danaher USD 2.07B 212M Jun/2026
Dentsply International USD 364M 13M Jun/2026
Deva Holding AS TRY 462.26M 48.18M Sep/2023
Dianthus Therapeutics USD 12.47M 5.89M Mar/2026
Divis Laboratories Ltd INR 3.4B 10M Jun/2025
Edwards Lifesciences USD 561.2M 39M Jun/2026
Illumina USD 273M 1000K Jun/2026
Intuitive Surgical USD 617.9M 4.6M Jun/2026
IQVIA Holdings USD 574M 72M Jun/2026
Kangmei Pharma CNY 237.06M 37.35M Mar/2026
Knight Therapeutics CAD 35.45M 4.43M Dec/2025
Laboratorios Farma EUR 35.32M 2.75M Jun/2025
Laboratory Of America USD 577.2M 26.2M Jun/2026
Malin Corporation EUR 1.1M 400K Dec/2024
Medical Developments International AUD 2.84M 4.19M Dec/2025
Mesa Laboratories USD 27.31M 380K Sep/2024
Mettler Toledo International USD 263.33M 5.01M Jun/2026
Myriad Genetics USD 122.3M 6.7M Dec/2025
Neuren Pharmaceuticals AUD 3.74M 2.5M Dec/2025
OraSure Technologies USD 13.21M 3.29M Dec/2025
Organigram Holdings CAD 22.01M 14.28M Mar/2026
Ovoca Bio EUR 617K 15K Dec/2025
Pacific Biosciences Of California USD 37.24M 25.68M Dec/2025
Pharma Mar EUR 17.12M 1.82M Jun/2026
Qiagen NV USD 142.33M 60K Jun/2026
Quest Diagnostics USD 529M 25M Jun/2026
Quidel USD 189.7M 9.6M Jun/2026
Repligen USD 76.62M 82K Jun/2026
Revvity USD 278.58M 24.69M Jun/2026
Sartorius EUR 221.3M 0 Jun/2026
Sino Biopharmaceutical CNY 7.54B 2.23B Jun/2025
Thermo Fisher Scientific USD 1.91B 111M Jun/2026
Tilray USD 24.85M 1.7M Sep/2025
Waters USD 405M 11M Jun/2026
Zealand Pharma A/S 104M 12.19M Mar/2026
Zz Pientze Pharmaceu CNY 223.14M 8.82M Jun/2026